EWA
IBB icon

Exencial Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Exencial Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Sell
2,219
-63
-3% -$10.8K 0.01% 448
2025
Q4 		$385K Hold
2,282
– – 0.01% 434
2025
Q3 		$329K Hold
2,282
– – 0.01% 435
2025
Q2 		$289K Sell
2,282
-297
-12% -$36.5K 0.01% 434
2025
Q1 		$330K Sell
2,579
-108
-4% -$14.6K 0.01% 416
2024
Q4 		$355K Buy
2,687
+1
+0% +$141 0.01% 409
2024
Q3 		$391K Sell
2,686
-299
-10% -$43.3K 0.01% 398
2024
Q2 		$410K Sell
2,985
-307
-9% -$41K 0.02% 384
2024
Q1 		$452K Sell
3,292
-174
-5% -$23.8K 0.02% 371
2023
Q4 		$471K Buy
3,466
+1
+0% +$122 0.02% 347
2023
Q3 		$424K Sell
3,465
-22
-0.6% -$2.8K 0.02% 313
2023
Q2 		$443K Buy
3,487
+86
+3% +$11.2K 0.02% 313
2023
Q1 		$439K Sell
3,401
-71
-2% -$9.29K 0.02% 300
2022
Q4 		$456K Buy
3,472
+121
+4% +$15.6K 0.02% 301
2022
Q3 		$392K Sell
3,351
-2,084
-38% -$259K 0.02% 307
2022
Q2 		$639K Sell
5,435
-2,586
-32% -$307K 0.04% 257
2022
Q1 		$1.04M Sell
8,021
-6,007
-43% -$782K 0.05% 231
2021
Q4 		$2.14M Buy
+14,028
New +$2.17M 0.1% 184
2021
Q3 		– Sell
-1,602
Closed -$262K – 378
2021
Q2 		$262K Sell
1,602
-58
-3% -$8.93K 0.01% 395
2021
Q1 		$250K Hold
1,660
– – 0.01% 374
2020
Q4 		$251K Sell
1,660
-1,530
-48% -$219K 0.02% 331
2020
Q3 		$432K Hold
3,190
– – 0.02% 273
2020
Q2 		$436K Buy
+3,190
New +$407K 0.04% 232
2020
Q1 		– Sell
-2,755
Closed -$332K – 252
2019
Q4 		$332K Sell
2,755
-450
-14% -$50.2K 0.06% 200
2019
Q3 		$319K Sell
3,205
-88
-3% -$9.21K 0.07% 193
2019
Q2 		$359K Sell
3,293
-300
-8% -$31.9K 0.08% 164
2019
Q1 		$402K Sell
3,593
-385
-10% -$42.2K 0.1% 158
2018
Q4 		$384K Buy
3,978
+711
+22% +$75.5K 0.1% 144
2018
Q3 		$398K Buy
3,267
+351
+12% +$41.3K 0.09% 129
2018
Q2 		$320K Buy
2,916
+90
+3% +$9.63K 0.09% 135
2018
Q1 		$302K Sell
2,826
-153
-5% -$17K 0.09% 138
2017
Q4 		$318K Sell
2,979
-723
-20% -$77.3K 0.1% 138
2017
Q3 		$412K Buy
3,702
+30
+0.8% +$3.21K 0.14% 121
2017
Q2 		$380K Buy
3,672
+315
+9% +$31K 0.16% 106
2017
Q1 		$323K Buy
3,357
+561
+20% +$53.7K 0.14% 111
2016
Q4 		$247K Buy
+2,796
New +$254K 0.1% 141

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Exencial Wealth Advisors's IBB Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its iShares Biotechnology ETF (IBB) stake by 2.8% in Q1 2026, selling an estimated $10.8K and leaving 2,219 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #448.

Exencial Wealth Advisors first reported a position in IBB in Q4 2016 and has held it in 36 quarters since. The position peaked at $2.14M in Q4 2021. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Exencial Wealth Advisors held 2,219 shares of iShares Biotechnology ETF worth $375K as of Q1 2026.
  • Exencial Wealth Advisors sold 63 iShares Biotechnology ETF shares in Q1 2026, an estimated $10.8K.
  • iShares Biotechnology ETF made up 0.01% of Exencial Wealth Advisors's portfolio in Q1 2026, its #448 holding.
  • Exencial Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 36 quarters since.
  • Exencial Wealth Advisors's iShares Biotechnology ETF position peaked at $2.14M in Q4 2021.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.